Health plans should work alongside PBMs and GLP-1 manufacturers to drive down costs, unlock rebates to further mitigate cost challenges and enhance drug commercialization (e.g., joint production partnerships, marketing partnerships)
Thus, optimizing GLP-1 therapies requires an integrated approach that supports adequate nutrition and physical activity, addresses body composition changes, and proactively manages GI side effects to maximize adherence and long-term clinical benefit
In addition, the products also claim to have Tirzepatide which is an antidiabetic medication used to treat type 2 diabetes and weight loss
Studies demonstrate that patients losing less than 5% body weight at early checkpoints rarely achieve clinically meaningful outcomes with continued treatment
Weight Change With Semaglutide
Some platforms allow free-text entry for both medications and medical conditions, which may increase the risk of users overlooking relevant health issues